Home › Kanser ng Endometrium › New Mexico › Albuquerque

Pag-aaral pangklinika para sa Kanser ng Endometrium sa Albuquerque, NM

Isang pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Albuquerque. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Nagre-recruitPhase 3

University of New Mexico Cancer Center, Albuquerque

Edad 18 pataas · Kababaihan · Na-update Okt 5, 2026 · NCT07198074

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2

University of New Mexico Cancer Center, Albuquerque

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Nagre-recruitPhase 1

University of New Mexico Cancer Center, Albuquerque

Edad 18 pataas · Kababaihan · Na-update Okt 2, 2026 · NCT05950464

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Nagre-recruitPhase 2

University of New Mexico Cancer Center, Albuquerque

Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Nagre-recruitPhase 2

Research Site, Albuquerque

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05489211

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Nagre-recruitPhase 3

University of New Mexico Comprehensive Cancer Center ( Site 6046), Albuquerque

Edad 18 pataas · Kababaihan · Na-update Set 17, 2026 · NCT06952504

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Nagre-recruitPhase 1/2

Research Site, Albuquerque

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05123482

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Nagre-recruitPhase 3

Research Site, Albuquerque

Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Nagre-recruitPhase 2

292, Albuquerque

Edad 18 pataas · Kababaihan · Na-update Hul 16, 2026 · NCT06906341

Uterine Preservation Via Lifestyle Transformation

Nagre-recruitPhase 2

University of New Mexico, Albuquerque

Edad 18 pataas · Kababaihan · Na-update Ene 20, 2026 · NCT05903131

Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Nagre-recruitPhase 1

University of New Mexico, Albuquerque

Edad 18 pataas · Kababaihan · Na-update Dis 11, 2025 · NCT06795009

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Albuquerque

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser ng Endometrium sa ibang lungsod

Iba pang pag-aaral sa Albuquerque

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.